Cyrus Therapeutics

Launch date

2019

Employees

Market cap

Enterprise valuation

Company register number 4428601643

South Korea (HQ)

http://cyrustx.com

https://www.linkedin.com/company/cyrus-therapeutics/

Date	Investors	Amount	Round
Sep 2020*	Kolon Investment Timefolio Asset Management Paratus Investment	KRW10.0b	Series A
Jan 2022*	Mirae Asset Venture Investment Atinum Investment Kolon Investment Timefolio Asset Management GC Pharma Paratus Investment	KRW29.0b	Series B
Total Funding		CAD44.6m